| Breakdown | TTM | Jun 2025 | Jun 2024 | Jun 2023 | Jun 2022 | Jun 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 3.89B | 3.42B | 2.88B | 2.65B | 2.26B | 1.88B |
| Gross Profit | 467.60M | 413.35M | 356.12M | 336.27M | 278.59M | 221.36M |
| EBITDA | 458.04M | 408.61M | 360.50M | 305.40M | 246.14M | 187.84M |
| Net Income | 374.09M | 332.53M | 296.18M | 247.91M | 200.38M | 148.34M |
Balance Sheet | ||||||
| Total Assets | 3.27B | 2.83B | 2.34B | 1.98B | 1.84B | 1.62B |
| Cash, Cash Equivalents and Short-Term Investments | 960.77M | 934.24M | 858.60M | 550.47M | 478.15M | 547.93M |
| Total Debt | 8.08M | 9.15M | 8.63M | 13.42M | 31.15M | 45.96M |
| Total Liabilities | 1.08B | 849.62M | 592.77M | 510.99M | 581.96M | 503.60M |
| Stockholders Equity | 2.18B | 1.98B | 1.75B | 1.47B | 1.25B | 1.11B |
Cash Flow | ||||||
| Free Cash Flow | 101.79M | 206.55M | 365.62M | 151.04M | 33.66M | 74.18M |
| Operating Cash Flow | 278.11M | 328.37M | 413.15M | 213.31M | 124.25M | 122.16M |
| Investing Cash Flow | -276.34M | -286.30M | -169.75M | -98.72M | -135.54M | -8.93M |
| Financing Cash Flow | -86.30M | -147.01M | -64.85M | -80.98M | -92.93M | -42.75M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | $20.99B | 56.18 | 18.72% | ― | 19.71% | 14.83% | |
74 Outperform | $5.46B | 31.72 | 12.63% | ― | 1.82% | 56.52% | |
73 Outperform | $28.12B | 40.64 | 47.87% | 0.14% | 13.18% | -38.37% | |
71 Outperform | $8.64B | 37.84 | 9.74% | ― | 7.40% | 13.79% | |
69 Neutral | $16.89B | 58.06 | 11.74% | 0.54% | 8.13% | 780.20% | |
63 Neutral | $47.78B | 252.24 | 3.63% | ― | 20.80% | ― | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% |
On December 11, 2025, Fabrinet, a company involved in the manufacturing sector, held its 2025 Annual General Meeting of Shareholders. At the meeting, approximately 95% of the total shares entitled to vote were represented. The shareholders elected Dr. Homa Bahrami and Caroline Dowling as Class I directors for a three-year term. Additionally, the shareholders ratified the appointment of PricewaterhouseCoopers ABAS Ltd. as the independent auditors for the fiscal year ending June 26, 2026, and approved the compensation of Fabrinet’s named executive officers.
The most recent analyst rating on (FN) stock is a Buy with a $545.00 price target. To see the full list of analyst forecasts on Fabrinet stock, see the FN Stock Forecast page.